Clinical Trial

Virtual Reality for Fibromyalgia

Study acronym: VR_Fibro
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Fibromyalgia is a frequent chronic pain syndrome almost often affecting women and associating diffuse chronic musculoskeletal pain (for more than 3 months), fatigue and sleep disturbances. Other varied functional symptoms are associated with it, in particular cognitive disorders and a feeling of unrested awakening. Technological advances in virtual reality have led to recognition by the medical community as a way to improve pain and quality of life for patients. There is a growing body of evidence supporting the use of virtual reality as an adjunct therapy to reduce acute pain in patients during medical procedures in hospital settings. There may also be a role for virtual reality in patients with chronic pain.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-10-03; most recent amendment 2025-03-10.
Status change: Recruiting → Active, Not Recruiting 2025-03-10
Status change: Not Yet Recruiting → Recruiting 2022-12-15
Trial Details
NCT Number NCT05567861
Lead Sponsor Centre Hospitalier Princesse Grace
Conditions Fibromyalgia
Enrollment 60 participants
Start Date 2022-10-11
Primary Completion 2024-12-01 (estimated)
Study Completion 2025-09 (estimated)
Updated on ClinicalTrials.gov 2025-03-12